KAICO
Techstars '22Nishiku, JP · 5 known investors
KAICO produces difficult-to-express proteins using silkworm technology for use as pharmaceuticals, diagnostic tools, and reagents. The company partners with pharmaceutical manufacturers to develop new drugs using its core platform for protein production in silkworms.
Investors · 5
Competitors · 1
by search overlapCompanies competing with KAICO for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does KAICO do?
- KAICO produces difficult-to-express proteins using silkworm technology for use as pharmaceuticals, diagnostic tools, and reagents. The company partners with pharmaceutical manufacturers to develop new drugs using its core platform for protein production in silkworms.
- Who are KAICO's investors?
- KAICO's investors include DG Incubation, Techstars, UntroD Capital, Itochu Technology Ventures, Mizuho Capital.
- Where is KAICO headquartered?
- KAICO is headquartered in Nishiku, JP.
